Characteristic | N | % or Mean | 95 % CI |
---|---|---|---|
Male (%) | 4833 | 48.11 | (46.79, 49.42) |
Age group (%) | |||
18–24 | 1444 | 18.94 | (17.73, 20.21) |
25–34 | 1819 | 24.63 | (23.25, 26.06) |
35–44 | 2461 | 23.03 | (21.81, 24.30) |
45–54 | 3562 | 18.01 | (17.03, 19.02) |
55–64 | 2106 | 10.34 | (9.61, 11.12) |
65+ | 602 | 5.05 | (4.47, 5.70) |
Hispanic background (%) | |||
Mexican/Mexican American | 4784 | 38.13 | (34.90, 41.46) |
Puerto Rican | 1809 | 15.09 | (13.58, 16.74) |
Cuban | 1753 | 19.61 | (16.54, 23.08) |
Dominican | 1084 | 10.02 | (8.68, 11.55) |
Central American | 1320 | 7.59 | (6.48, 8.86) |
South American | 854 | 5.28 | (4.63, 6.02) |
Other | 390 | 4.28 | (3.68, 4.96) |
Body mass index (BMI; kg/m2) | 28.88 | (28.68, 29.08) | |
Waist circumference (cm) | 95.90 | (95.44, 96.36) | |
Obese (BMI ≥ 30 kg/m2) | 4597 | 36.86 | (35.37, 38.38) |
Abdominal adiposity | 6818 | 51.44 | (49.82, 53.05) |
Systolic blood pressure (mmHg) | 118.32 | (117.85, 118.79) | |
Diastolic blood pressure (mmHg) | 71.79 | (71.43, 72.15) | |
Fasting glucose (mg/dL) | 93.51 | (93.28, 93.74) | |
Fasting insulin (mU/L) | 12.06 | (11.78, 12.34) | |
HbA1c (%) | 5.41 | (5.40, 5.42) | |
HOMA-IR (index) | 2.83 | (2.76, 2.90) | |
Current smoking | 2382 | 21.86 | (20.60, 23.17) |
Coronary heart disease | 416 | 3.19 | (2.71, 3.75) |
Self-reported heart failure | 132 | 0.87 | (0.68, 1.10) |
Beta blocker use | 520 | 3.24 | (2.86, 3.66) |
Non-hydropyridine calcium channel blocker use | 300 | 1.98 | (1.63, 2.41) |
Sympathomimetic medication use | 441 | 3.50 | (3.01, 4.07) |